AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Uproar over COX-2 inhibitors alters landscape of drug trials.(Clinical Rounds)

OB GYN News

| May 01, 2005 | Wendling, Patrice | COPYRIGHT 2005 International Medical News Group. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

CHICAGO -- Recent events surrounding selective cyclooxygenase-2 inhibitors will have far-reaching implications for future drug trials, Gary S. Hoffman, M.D., said at a symposium sponsored by the American College of Rheumatology.

Drugs under investigation for chronic diseases such as arthritis will require longer trials and follow-up than in the past, in part because of their likely long-term use among the patients who need them.

"We can no longer endorse or not endorse these drugs based upon short-term studies, some of which have been as short as 6 weeks or 12 weeks and usually, certainly, less than a year," said Dr. Hoffman, a member of the Food and Drug Administration's arthritis advisory committee.

NSAID trials now will include cardiovascular and thrombotic events among the adverse events they monitor.

But this raises questions as to whether there are other adverse events (AEs) such as cancer, autoimmune effects, or neurocognitive dysfunction that are beyond our current knowledge, said Dr. Hoffman, professor of medicine and chair of rheumatic and immunologic diseases at the Cleveland Clinic Foundation.

...

Related articles from newspapers, magazines, journals, and more
Drug companies should disclose adverse events before licensing.
Newspaper article from: Health & Medicine Week November 8, 2004 700+ words
...companies disclosed adverse events before licensing. Single phase III drug trials are simply not big...uncommon but important adverse events, which may affect...impact of undetected adverse events is likely to be made...
Disclose Rx AEs before licensing, says study.(adverse events)(Brief Article)
Newspaper article from: Pharma Marketletter October 25, 2004 700+ words
...drugmakers disclosed adverse events before licensing. Single Phase III drug trials are simply not big...uncommon but important adverse events, which may affect...unbiased evidence on adverse events before a drug is fully...
COX-2 inhibitor uproar will alter landscape of drug trials.(Rheumatology)
Magazine article from: Internal Medicine News Wendling, Patrice May 1, 2005 700+ words
...implications for future drug trials, Gary S. Hoffman, M...thrombotic events among the adverse events they monitor. But this...whether there are other adverse events such as cancer, autoimmune...there other important [adverse events] that we should also be...
Cancer drug trials stopped "before risks and benefits have been properly...
Newspaper article from: Pharma Marketletter April 14, 2008 700+ words
...Oncology shows that the number of cancer drug trials stopped early because they demonstrated...years for the long-term benefits or adverse events of a treatment to become apparent...drug resistance, metastasis, or adverse events, all factors that weight heavily in...
PLACEBO RATE FORCES NPS TO SEEK NEW NPS 1776 INDICATION.(NPS Pharmaceuticals...
Magazine article from: BIOWORLD Today Pihl-Carey, Karen October 13, 2004 700+ words
...the low dose and 56 percent of those receiving placebo. Study results also showed no serious adverse events in any of the subjects. Adverse events were infrequent and evenly distributed between the study groups. The pharmacokinetic profile...
Biogen halts drug trials.
Newspaper article from: The Boston Herald Powell, Jennifer Heldt November 3, 1999 700+ words
...changed from our earlier announcement," said Biogen Chief Jim Vincent. "We need further study of the reasons for these adverse events and in the interest of patient safety." Biogen disclosed the action after regular trading had ended on Wall Street. But...
Smallpox vaccine adverse events among civilians -- United States, February...
Newspaper article from: Morbidity and Mortality Weekly Report February 28, 2003 700+ words
...surveillance for vaccine-associated adverse events. In the first stage of the program...moderate-to-severe, and other serious adverse events and for vaccinia transmission to contacts...report summarizes smallpox vaccine adverse events reported among civilians vaccinated...
Update: Adverse Events following civilian smallpox vaccination - United States,...
Newspaper article from: Morbidity and Mortality Weekly Report May 16, 2003 700+ words
...information on vaccine-associated adverse events among civilians vaccinated since the...surveillance for vaccine-associated adverse events among civilian vaccinees (1). As...routine follow-up, and reported adverse events after vaccination receive follow...
For more facts and information, see all results
©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA